BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 24958634)

  • 1. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
    Sthoeger Z; Sharabi A; Mozes E
    J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belimumab therapy in systemic lupus erythematosus.
    Zouali M; Uy EA
    BioDrugs; 2013 Jun; 27(3):225-35. PubMed ID: 23568179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations on the use of belimumab in systemic lupus erythematosus. GEAS-SEMI Clinical Practice Guide].
    Ramos-Casals M; Ruiz-Irastorza G; Jiménez-Alonso J; Khamashta MA;
    Rev Clin Esp (Barc); 2013; 213(1):42-58. PubMed ID: 23266125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
    Mosak J; Furie R
    Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Belimumab: targeted therapy for lupus.
    Chugh PK; Kalra BS
    Int J Rheum Dis; 2013 Feb; 16(1):4-13. PubMed ID: 23441766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biological treatments for systemic lupus erythematosus: current and future modalities.
    Bezalel S; Asher I; Elbirt D; Sthoeger ZM
    Isr Med Assoc J; 2012 Aug; 14(8):508-14. PubMed ID: 22977972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosus.
    Mozes E; Sharabi A
    Autoimmun Rev; 2010 Nov; 10(1):22-6. PubMed ID: 20659591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
    Lo MS; Tsokos GC
    Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belimumab for systemic lupus erythematosus: a practice-based view.
    Parodis I; Axelsson M; Gunnarsson I
    Lupus; 2013 Apr; 22(4):372-80. PubMed ID: 23553780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologicals for the treatment of systemic lupus erythematosus: current status and emerging therapies.
    Leone A; Sciascia S; Kamal A; Khamashta M
    Expert Rev Clin Immunol; 2015 Jan; 11(1):109-16. PubMed ID: 25511179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
    Murphy G; Lisnevskaia L; Isenberg D
    Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus: novel therapies in clinical development.
    Chugh PK
    Eur J Intern Med; 2012 Apr; 23(3):212-8. PubMed ID: 22385876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?
    Runkel L; Stacey J
    Expert Opin Biol Ther; 2014 Apr; 14(4):491-501. PubMed ID: 24490627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Treatments in Lupus.
    Kyttaris VC
    Curr Rheumatol Rep; 2017 Mar; 19(3):10. PubMed ID: 28265845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic avenues in SLE.
    Bakshi J; Ismajli M; Rahman A
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):794-809. PubMed ID: 27107514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New targets in systemic lupus (part 2/2).
    Sifuentes Giraldo WA; García Villanueva MJ; Boteanu AL; Lois Iglesias A; Zea Mendoza AC
    Reumatol Clin; 2012; 8(5):263-9. PubMed ID: 22483664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.